Physical markers of individual radiosensitivity

56

No. 412 in all physics · No. 17 in Medical and Radiation Physics

Non-expert version

Identify an assay predicting severe normal-tissue reaction, defined as grade 3 or higher toxicity, before treatment, with sensitivity and specificity sufficient for clinical use. Candidate physical and cellular measures: residual DNA double-strand break foci at 24 h, chromosome aberration yield per 100 rad in lymphocytes, and apoptosis fraction after ex vivo irradiation. An answer names a validated assay with its operating characteristics.

What would settle it

Prospective blinded validation of a candidate assay against observed toxicity in a treated cohort.

Status in the literature

A lymphocyte apoptosis assay was validated prospectively for late breast fibrosis in 2015 (Azria et al., EBioMedicine), with discrimination too modest for routine clinical use.

No solutions, ideas or subproblems yet.

How results are checked

Comments (0)

Comments are not records: they are not signed, stamped or logged. How comments work

No comments yet.

Sign in to comment.

Details, signature and history
Kind
Well-posed question
Answer
Identification
Posed
1990
Topic review
Brenner et al., Cancer risks attributable to low doses of ionizing radiation: assessing what we really know, Proceedings of the National Academy of Sciences, 2003. Link
Record
Revision 1 · imported from the seed collection · compiled by AI, not yet reviewed by an editor

Proof

Fingerprint
838b9bda30ff…
Public log
Entry 1,697, in checkpoint 2,123
In the log by
Block 969,698, 2026-10-03

This text was in the PubPhys log by that date. The date says nothing about when the problem was first posed.

History